Altre lingue SOCL CAPI

Azioni

DNAC

KYG8253W1096

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
2,12 ^USD	-21,77%		+3,92%	-78,46%

2022	Social Capital Suvretta Holdings Corp. III riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 giugno 2022	CI
2022	ProKidney completa la fusione SPAC con Social Capital Suvretta Holdings; le azioni inizieranno la negoziazione al Nasdaq	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22
SOCL CAPI : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	15/07/22
ProKidney Completes SPAC Merger With Social Capital Suvretta Holdings; Shares to Start Nasdaq Trading	12/07/22
Social Capital Suvretta III : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	12/07/22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III	12/07/22
Social Capital Suvretta Holdings Corp. III(NasdaqCM:DNAC) dropped from NASDAQ Composite Index	12/07/22
Social Capital Suvretta III : Announces Reconvened Extraordinary General Meeting of Shareholders - Form 8-K	11/07/22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	11/07/22
ProKidney LLC completed the acquisition of Social Capital Suvretta Holdings Corp. III from SCS Sponsor III LLC, Millennium Management LLC, Adage Capital Management, L.P. and others in a reverse merger transaction.	11/07/22
Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders	09/07/22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Other Events (form 8-K)	06/07/22
Social Capital Suvretta III : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K/A	10/06/22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III Other Events, Financial Statements and Exhibits (form 8-K/A)	10/06/22
Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 Update	07/06/22
ProKidney to present at upcoming investor conferences	20/05/22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/05/22
Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	28/04/22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22/04/22
Social Capital Suvretta Holdings Corp. III Issues an Unsecured Promissory Note	22/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue SOCL CAPI

Azioni

DNAC

KYG8253W1096

Altre lingue

Filtri